Pfizer | pharmaphorum

Thursday 28 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

Pfizer

News

Pyxis_Oncology_logo

Pyxis follows Pfizer alliance with $152m fundraising for can...

Fresh from a licensing agreement with Pfizer, US startup Pyxis Oncology has raised a sizeable $152 million in second-round financing led by venture capital groups Arix Bioscience and RTW In

News

Illustration of a nerve cell on a colored background with light effects

Thumbs-down from FDA experts for Pfizer/Lilly's painkiller t...

After more than a decade of fraught clinical development it looks like the end of the line for Pfizer/Lilly painkiller tanezumab, which promised to be an alternative to addictive opioid pai

News

SARS-CoV-2

Pfizer begins clinical trials of COVID-19 antiviral pill

Pfizer has begun clinical development of an antiviral pill against COVID-19, which could be prescribed to patients at the first sign of infection.

Events

PharmaPhorum1

Partner Content

RBQM Live: The Definitive Guide to RBQM for Experts and Begi...

RBQM Live two-day virtual event May 20-21

News

Red spine and vertebral column of a human skeleton

FDA worried about Pfizer/Lilly pain drug safety ahead of key...

After a long and troubled development the fate of Pfizer/Lilly’s tanezumab painkiller injection is in the balance ahead of a key meeting of advisers later this week.

News

Cancer-cell

Belgium's eTheRNA gets EU grant to develop mRNA cancer vacci...

Belgian immunotherapy firm eTheRNA has received a €6.9 million grant from the European Commission to accelerate clinical development of mRNA therapies for hard-to-treat cancers.